COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed indirect comparisons.
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Столичная издательская компания
2015-09-01
|
| Collection: | Рациональная фармакотерапия в кардиологии |
| Sujets: | |
| Accès en ligne: | https://www.rpcardio.online/jour/article/view/109 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|